Dengue is a mosquito-borne infectious disease affecting humans and animals caused by dengue virus belonging to the Flaviviridae family and genus Flavivirus. Dengue is typically transmitted from human to human through the bite of an infected aedes aegypti mosquito. Symptoms of dengue include high fever, headache, fatigue, muscle pain, diarrhea, anemia, skin rashes and vomiting. Severe dengue can cause yellow skin, seizures, coma, or death. Dengue has high mortality rate and can cause various complications in the neurology. The global dengue vaccine market is anticipated to record a CAGR of around 23 % over the forecast period.

Top Driver: rising number of dengue cases observed around the world

Growing clinical advancements observed in the development of vaccines for dengue fever along with the concern for dengue disease occurring worldwide are anticipated to contribute towards the growth of the global dengue vaccine market. According to the statistics by the World Health Organization (WHO), the total number of dengue cases around the world has observed over fifteen-fold increase, raising the number to reach a total of up to 3,312,040 numbers in the year 2015.

Also, the market is primarily driven by the rising number of dengue cases observed around the world, which is affecting millions of people, thereby raising the need to get vaccinated by dengue vaccine. According to the World Health Organization, around 100-400 million dengue infections were estimated around the globe to occur each year. The statistics also stated that more than half of the world’s population is at risk of getting affected from dengue fever.

Hospitals pharmacies measurement-type to Make Crucial Contribution to Growth of Tunable Diode Laser Analyzer Market

Based on distribution channel, the market has been classified into hospital pharmacies, retail pharmacies, drug store, online pharmacies, and others. The hospitals pharmacies segment held the largest share of the market due to easy access for outpatient department (OPD) patients to buy medicines. Online pharmacies are likely to witness lucrative growth during the forecast period due to increasing online purchase by patients and various discounts offered by online stores.

The global dengue vaccine market is segmented into end-user type such as government institutions and private institutions. Among these segments, government institutions segment is expected to occupy the top position in the market during the forecast period. The rise of the government institution segment is backed by favorable government initiatives and programs to provide Dengue Vaccines to the population at affordable price. Further, increasing number of patients suffering from dengue infection and improving healthcare infrastructure are major factors which are escalating the growth of dengue vaccine market across the globe. 

North America expected to witness fastest growth in Dengue Vaccine  Market

North America (U.S. and Canada), Europe (Germany, France, U.K., etc.), Asia Pacific (Australia, China, Japan, India, etc.), Latin America (Brazil, Mexico, etc.), and Middle East &Africa (GCC Countries, South Africa, etc.). North America is the leading market for dengue vaccine in terms of revenue, followed by Europe. The U.S. holds the largest share of the market in the region. Asia Pacific and Latin America are emerging markets, which are expected to witness strong growth during the forecast period from 2017 to 2025. Strong growth in these regions is attributed to increasing incidence of dengue, rising health care industries, and increase in government investment to develop health care infrastructure. The dengue vaccine market in countries such as China, India, and Brazil is projected to expand at high growth rate during the forecast period due to increase in awareness among the population about dengue disease and its treatment.

Players to Focus on Dengue Vaccine Market

Major Players operating in the dengue vaccine market include

• Sanofi Pasteur,
• Panacea Biotec,
• Biological E. Limited,
• GlaxoSmithKline plc,
• Merck & Co., Inc.
• Takeda Pharmaceutical Company Ltd.

Scope of the Report

By End user

• hospitals pharmacies
• Government Institutions
• Private Institutions

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report 

1. It provides a technological development map over time to understand the growth rate of the industry.

2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.

3. It renders definite analysis for changing competitive dynamics.

4. It builds a seven-year estimate based on how the market is predicted to grow.